Retirement Guys Formula LLC Has $2.37 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Retirement Guys Formula LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,055 shares of the healthcare conglomerate’s stock after selling 42 shares during the quarter. UnitedHealth Group accounts for approximately 1.1% of Retirement Guys Formula LLC’s investment portfolio, making the stock its 19th biggest position. Retirement Guys Formula LLC’s holdings in UnitedHealth Group were worth $2,371,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. Harbor Investment Advisory LLC boosted its holdings in shares of UnitedHealth Group by 3.2% during the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after acquiring an additional 1,129 shares in the last quarter. Austin Private Wealth LLC lifted its holdings in UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after buying an additional 111 shares during the period. Capital Insight Partners LLC lifted its holdings in UnitedHealth Group by 3.8% during the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after buying an additional 332 shares during the period. Global Assets Advisory LLC acquired a new position in UnitedHealth Group during the 1st quarter worth about $282,469,000. Finally, Tealwood Asset Management Inc. acquired a new position in UnitedHealth Group during the 3rd quarter worth about $2,905,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. UBS Group lowered their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday, October 16th. Barclays lifted their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Finally, Stephens decreased their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.58.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $3.63 during trading on Monday, hitting $573.24. The stock had a trading volume of 1,709,244 shares, compared to its average volume of 3,955,370. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock’s 50 day moving average is $584.42 and its two-hundred day moving average is $534.68. The stock has a market cap of $529.34 billion, a price-to-earnings ratio of 37.11, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the firm posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.47%. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.